CellSource Co.,Ltd.

4880

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-09-08FY2026 Q3

Revenue

34.5100M JPY

YoY -9.9%

Operating Income

1.8100M JPY

YoY +45.3%

Net Income

98,867,000JPY

YoY +297.8%

EPS

8.8JPY

YoY +102.3%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

45.1億円

33.8億円

22.6億円

11.3億円

Rev: 29.2億円Op: 9.9億円NI: 6.5億円

Rev: 42.7億円Op: 15.7億円NI: 10.2億円

Rev: 45.1億円Op: 12.2億円NI: 9.2億円

Rev: 43.6億円Op: 1.3億円NI: 2.4億円

Rev: 37.1億円Op: 1.7億円NI: 10.7百万円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q3

Net Income-

Revenue Progress25.600M

Revenue Forecast33.700M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan